Greenwich LifeSciences (GLSI) EPS (Basic) (2019 - 2025)
Greenwich LifeSciences (GLSI) posted EPS (Basic) of -$1.27 for Q4 2025, down 317.49% on a QoQ basis from -$0.3 in Q3 2025, and down 1.43% year-over-year from -$1.29 in Q4 2024.
Greenwich LifeSciences (GLSI) EPS (Basic) (2019 - 2025) Analysis & Trends
Greenwich LifeSciences' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$1.27 for Q4 2025.
- Quarterly EPS (Basic) fell 1.43% year-over-year to -$1.27 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.12 (down 14.47% YoY) and the FY2025 annual result came in at -$2.12, down 14.47% from the prior year.
- EPS (Basic) was -$1.27 for Q4 2025 at Greenwich LifeSciences, down from -$0.3 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.05 in Q1 2021 and bottomed at -$1.27 in Q4 2025.
- A 5-year average of -$0.32 and a median of -$0.2 in 2024 frame the typical range for EPS (Basic).
- Peak annual rise in EPS (Basic) reached 0.7% in 2022, while the deepest fall reached 223.27% in 2022.
- Greenwich LifeSciences' EPS (Basic) stood at -$0.3 in 2021, then tumbled by 53.34% to -$0.46 in 2022, then fell by 22.96% to -$0.56 in 2023, then plunged by 121.96% to -$1.25 in 2024, then slipped by 1.43% to -$1.27 in 2025.
- Business Quant data shows GLSI's EPS (Basic) at -$1.27 in Q4 2025, -$0.3 in Q3 2025, and -$0.3 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Greenwich LifeSciences | 178.53 Mn | 178.53 Mn | - | -1.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.27 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.25 |
| Dec 31, 2024 | -1.25 |
| Sep 30, 2024 | -0.20 |
| Jun 30, 2024 | -0.20 |
| Mar 31, 2024 | -0.19 |
| Dec 31, 2023 | -0.56 |
| Sep 30, 2023 | -0.19 |
| Jun 30, 2023 | -0.13 |
| Mar 31, 2023 | -0.17 |
| Dec 31, 2022 | -0.46 |
| Sep 30, 2022 | -0.18 |
| Jun 30, 2022 | -0.06 |
| Mar 31, 2022 | -0.15 |
| Dec 31, 2021 | -0.30 |
| Sep 30, 2021 | -0.07 |
| Jun 30, 2021 | -0.06 |
| Mar 31, 2021 | -0.05 |